Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amanda M. Esch
Observed names:
A Esch,
Amanda Esch,
Esch, Amanda
Institution:
Standard BioTools (United States)
Observed institutions:
University of Wisconsin–Madison,
Oregon Health & Science University,
Rensselaer Polytechnic Institute,
Aristotle University of Thessaloniki,
Yale University,
Fluidigm (Canada),
University General Hospital Attikon,
Standard BioTools (United States)
show all 8
ORCID:
0000-0002-4355-7162
Observed ORCID:
0000-0002-4355-7162
OpenAlex ID:
A5087541423
Combating subclonal evolution of resistant cancer phenotypes
2017
·
Samuel W. Brady
, Jasmine A. McQuerry
, et al.
·
Nature Communications
·
164
PDF
Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry
2019
·
Daniel E. Carvajal-Hausdorf
, Jonathan Patsenker
, et al.
·
Clinical Cancer Research
·
49
PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder
2016
·
Anna Brown
, Siddharth Patel
, et al.
·
Scientific Reports
·
48
PDF
Multidimensional profiling of drug‐treated cells by Imaging Mass Cytometry
2019
·
Alexandre Bouzekri
, Amanda Esch
, et al.
·
FEBS Open Bio
·
46
PDF
Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2017
·
Saima Hassan
, Amanda Esch
, et al.
·
Molecular Cancer Therapeutics
·
31
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer
2016
·
Zhi Hu
, Jian-Hua Mao
, et al.
·
Breast Cancer Research
·
31
PDF
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
2015
·
James E. Korkola
, Eric A. Collisson
, et al.
·
PLoS ONE
·
25
PDF
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA
2021
·
Joseph P. Garay
, Rebecca Smith
, et al.
·
Breast Cancer Research
·
18
PDF
Wnt signaling can substitute for estrogen to induce division of ERα-positive cells in a mouse mammary tumor model
2009
·
Melissa Mastroianni
, Soyoung Kim
, et al.
·
Cancer Letters
·
18
The Biomechanical Environment and Impact on Tissue Fibrosis
2016
·
Wayne Carver
, Amanda M. Esch
, et al.
·
Springer eBooks
·
6
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes
2018
·
Samuel W. Brady
, Jasmine A. McQuerry
, et al.
·
Nature Communications
·
4
PDF
Production and characterization of monoclonal antibodies to estrogen-related receptor alpha (ERRα) and use in immunoaffinity chromatography
2012
·
Amanda M. Esch
, Nancy E. Thompson
, et al.
·
Protein Expression and Purification
·
4
Abstract 1635: Multiplexed analysis of fixed tumor tissues using imaging mass cytometry
2017
·
Franz Villarroel-Espindola
, Daniel Carvajal-Hausdorf
, et al.
·
Cancer Research
·
2
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer
2017
·
Zhi Hu
, Jian-Hua Mao
, et al.
·
Breast Cancer Research
·
2
PDF
Biological indicators of response and resistance to PARP inhibition in BRCA wild-type breast cancer.
2015
·
Saima Noor Hassan
, Amanda Esch
, et al.
·
Journal of Clinical Oncology
·
2
Abstract 4700: BET bromodomain inhibition is a promising treatment strategy for distinct subsets of lethal castration-resistant prostate cancer
2016
·
Lina Gao
, Daniel J. Coleman
, et al.
·
Cancer Research
·
1
A Computational Workflow for Cell Line Profiling by Imaging Mass Cytometry
2026
·
Alexandre Bouzekri
, Amanda Esch
, et al.
·
Cytometry Part A
Supplementary File 1_Rank List from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
Supplementary Figures S4-S12 from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
PDF
Supplementary File 3_Core Enriched Genes from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
Supplementary Tables S1-S4 from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
PDF
Supplementary File 2_Gene Sets from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
Supplementary File 4_Reactome Pathway Analysis from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
Supplementary Figures S1-S3 from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
Data from Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
2023
·
Saima Hassan
, Amanda Esch
, et al.
Show more works
View as search
Works count:
46
Citation count:
451
H-index:
9
I10-index:
9
Year
Topic
Type